#77 Strong Clinical Relevance
High-quality evidence with meaningful patient or clinical significance.
This study reveals that both indica and sativa strains of cannabis typically have comparable THC and CBD concentrations. However, the significant distinction lies in their terpene profiles, which may influence the therapeutic effects, particularly for anxiety relief. Clinicians should consider a patient’s response to specific terpenes when recommending cannabis strains for managing anxiety symptoms.
🌿 In a recent study, it was found that indica and sativa strains of cannabis, while often categorized differently, tend to have comparable levels of THC and CBD on average. However, the significant distinction lies in their terpene profiles. (1) As healthcare providers, this finding underscores the complexity of cannabis’s effects on anxiety, suggesting that the therapeutic potential may not solely rely on cannabinoid content but also on the specific blend of terpenes. (2) Confounders such as individual sensitivity to terpenes and potential interactions with other medications should be considered when recommending cannabis for anxiety management. (3) Practically, this implies a need for personalized approaches in prescribing cannabis, taking into account each patient’s unique response to different terpene profiles to optimize relief while minimizing the risk of exacerbating anxiety symptoms.
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
